Olivier Tytgat

Olivier Tytgat started their work experience as a PhD student at imec in 2018. Olivier then moved on to work as a PhD student at Universiteit Gent until August 2022. Following this, they became a Postdoctoral Researcher at Universiteit Gent until April 2023. Currently, Olivier is working as a Business Development Analyst at Ziphius Vaccines, starting in April 2023.

Olivier Tytgat has pursued a comprehensive education in the field of pharmacy and drug development. Olivier obtained a Doctor of Pharmacy (PharmD) degree from Ghent University, completing their studies from 2018 to 2022. Prior to this, they earned a Master of Science (MS) degree in Drug Development from the same institution, studying from 2016 to 2018. Olivier's foundation in pharmaceutical sciences was established during their undergraduate years at Ghent University, where they obtained a Bachelor of Science (BS) degree from 2013 to 2016. Apart from their academic achievements, Olivier has also pursued additional certifications in New Business Development at Vlerick Business School.